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Available online 6 April 2016Background: Individuals with autism spectrum disorder (ASD) show atypical brain activity, perhaps due to de-
layed maturation. Previous studies examining the maturation of auditory electrophysiological activity have
been limited due to their use of cross-sectional designs. The present study took a ﬁrst step in examining magne-
toencephalography (MEG) evidence of abnormal auditory responsematuration in ASD via the use of a longitudi-
nal design.
Methods: Initially recruited for a previous study, 27 children with ASD and nine typically developing (TD) chil-
dren, aged 6- to 11-years-old, were re-recruited two to ﬁve years later. At both timepoints, MEG data were ob-
tained while participants passively listened to sinusoidal pure-tones. Bilateral primary/secondary auditory
cortex time domain (100 ms evoked response latency (M100)) and spectrotemporal measures (gamma-band
power and inter-trial coherence (ITC)) were examined. MEG measures were also qualitatively examined for
ﬁve children who exhibited “optimal outcome”, participants who were initially on spectrum, but no longer
met diagnostic criteria at follow-up.
Results:M100 latencieswere delayed inASDversus TDat the initial exam(~19ms) and at follow-up (~18ms). At
both exams, M100 latencies were associated with clinical ASD severity. In addition, gamma-band evoked power
and ITCwere reduced in ASD versus TD. M100 latency and gamma-bandmaturation rates did not differ between
ASD and TD. Of note, the cohort of ﬁve children that demonstrated “optimal outcome” additionally exhibited
M100 latency and gamma-band activity mean values in-between TD and ASD at both timepoints. Though justi-
fying only qualitative interpretation, these “optimal outcome” related data are presented here tomotivate future
studies.
Conclusions: Children with ASD showed perturbed auditory cortex neural activity, as evidenced byM100 latency
delays as well as reduced transient gamma-band activity. Despite evidence for maturation of these responses in
ASD, the neural abnormalities in ASD persisted across time. Of note, data from the ﬁve children whom demon-
strated “optimal outcome”qualitatively suggest that such clinical improvementsmay be associatedwith auditory
brain responses intermediate between TD and ASD. These “optimal outcome” related results are not statistically
signiﬁcant though, likely due to the low sample size of this cohort, and to be expected as a result of the relatively
low proportion of “optimal outcome” in the ASD population. Thus, further investigations with larger cohorts are
needed to determine if the above auditory response phenotypes have prognostic utility, predictive of clinical
outcome.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Maturation1. Introduction
Autism spectrum disorder (ASD) describes a group of disorders char-
acterized by social/communication impairments and restricted/repetitive
behaviors (American Psychiatric Association, 2013). Recent prevalence
estimates report that 1 in 68 children have ASD (Developmentalerts).
. This is an open access article underDisabilities Monitoring Network Surveillance Year 2010 Principal
Investigators and Centers for Disease Control and Prevention (CDC),
2014). Given that interventions to treat symptoms association with ASD
show variable success (Dawson et al., 2010; Erickson et al., 2014; Van
Hecke et al., 2013), and given that treatment outcome is difﬁcult to pre-
dict at treatment onset, there is a need for early response indicators. Pre-
clinical studies of novel treatment efﬁcacy are also hampered by the lack
of directly translatable clinical/preclinical metrics such as brain activity
proﬁles; as a result preclinical studies primarily rely on behavioral assays.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ed features of ASD (Silverman et al., 2010), no behavioral assay fully char-
acterizes the full complexity of ASD. Furthermore, the degree to which
this is possible has been questioned (Crawley, 2007). “Biomarkers” offer
a biological target for therapeutics, a bridge between preclinical and clin-
ical studies, and may serve as early response indictors of treatment suc-
cess/failure (Port et al., 2014, 2015).
Two prospective brain biomarkers, superior temporal gyrus (STG)
M100 auditory latency (Edgar et al., 2014b; Gage et al., 2003b; Roberts
et al., 2010) and STG post-stimulus auditory gamma-band activity
(Edgar et al., 2015b, 2016; Gandal et al., 2010; Wilson et al., 2007),
have been identiﬁed as abnormal in ASD as well as in animal models
that recapitulate key aspects of ASD (Engineer et al., 2014; Gandal
et al., 2010). The auditory M100 response and it's electrical counterpart
(N1) are electrophysiological responses seen in auditory event-related
ﬁelds/potentials (ERF/P) approximately 100 ms after a stimulus (Hari
et al., 1980). M100 responses become stronger and observed at earlier
latencies as a function of typical development (Edgar et al., 2014b;
Paetau et al., 1995). First described by Gage and colleagues in our
group (Gage et al., 2003a), right-hemisphere auditory M100 latencies
were observed to be delayed by ~10% in children with ASD versus
age-matched typically developing controls (TD). This ~10 ms right-
hemisphere M100 latency prolongation in children with ASD versus
TDwas observed in later studies, with group differences in M100 laten-
cy remaining even after co-varying cognitive and language ability
(Edgar et al., 2014b, 2015b; Roberts et al., 2010). Notably, in several re-
ports, the M100 latency delay in ASD exhibited hemispheric speciﬁcity.
Hemispheric speciﬁcity is germane to, and elucidated by, the large body
of studies regarding hemispheric differences in speech processing
(Hickok and Poeppel, 2015). Studies examining the hemispheric asym-
metry of speech processing demonstrate face validity for theM100 ASD
latency ﬁndings given the social communication deﬁcits observed in
ASD. For example, Poeppel (2003) hypothesized that hemisphere differ-
ence in processing speech arises from a left-hemisphere preference for
processing auditory information over short integration windows and a
right-hemisphere preference for processing auditory information over
longer windows. Similarly, Zatorre and Belin (2001) suggested that
the left-hemisphere specializes in rapid temporal processing and the
right-hemisphere processes spectral signals. Both hypotheses converge
on the idea that the left-hemisphere is involved in processing short du-
ration speech-speciﬁc stimuli, such as phonemes, whereas the right-
hemisphere is involved in processing long duration information such
as prosody, or alternatively, the melody of music (Tervaniemi and
Hugdahl, 2003). The processing of non-speech sounds may be funda-
mentally homologous to speech sounds if the non-speech sound is of
sufﬁcient complexity (for review see Zatorre and Gandour, 2008). In
contrast to sampling-rate based hypotheses, McGettigan and Scott
(2012) suggested a mixed model of speech processing, where the left-
hemisphere utilizes domain-speciﬁc functioning based on experience-
driven plasticity and the right-hemisphere utilizes domain general pro-
cessing. Regardless, the right-hemisphere M100 delay in ASD may be
associatedwith downstream issues in processing percepts such as pros-
ody and emotional intonation, rather than basic phonemes.
Later studies that recapitulated M100 latency delays in individuals
with ASD versus TD also observed that M100 latency maturation rates
did not differ between TD and ASD (Roberts et al., 2010). This suggested
that the persistent delay in auditory M100 latencies in children as well
as adolescentswith ASDwas due to an early initialM100 latency ‘offset’.
As demanded of any biomarker, auditoryM100 latencies delays have
plausible biological bases, with either disruptions to neural signal con-
duction and/or synaptic transduction leading to latency prolongation
(Port et al., 2015). For instance, ERP/F component latencies, including
auditory M100 latencies, have been associated with underlying white-
matter microstructure (Dockstader et al., 2012; Roberts et al., 2009;
Stufﬂebeam et al., 2008). While thalamocortical white-matter micro-
structure may be intact in ASD, the developmental trajectory of white-mattermicrostructure, aswell as the association ofwhite-mattermicro-
structure with ERF component latency, are not (Roberts et al., 2013).
Additionally, individuals with genetic copy number variations related
to ASD, speciﬁcally deletions in the 16p11.2 locus, demonstrated a sim-
ilar uncoupling of white-matter microstructure and ERF component la-
tency (Berman et al., 2016).
In addition to alterations in signal conduction, multiple laboratories
have found alterations with respect to signal transduction in ASD. In
particular, perturbations related to synaptic transmission have been ob-
served clinically in in-vivo (Brown et al., 2013; Gaetz et al., 2014;
Harada et al., 2011; for review see Rojas et al., 2014, 2015), in postmor-
tem studies (Fatemi et al., 2002, 2009b, 2014; Oblak et al., 2010), aswell
as in preclinical reports (Gogolla et al., 2009; Gogolla et al., 2014; K.
Zhang et al., 2014; Gandal et al., 2012; Banerjee et al., 2013; Cellot and
Cherubini, 2014; Han et al., 2012). As such, M100 latency deﬁcits may
be a non-invasive probe of local neural circuit functioning in ASD.
Preclinical studies have suggested that middle latency responses
analogous to theM100 are associated with sociability inmurinemodels
relevant to ASD (Billingslea et al., 2014; Saunders et al., 2013). In addi-
tion, behavioral interventions for ASD targeting social or language func-
tioning have been observed to partially normalize the latency of cortical
responses (Dawson et al., 2012; Russo et al., 2010). An association be-
tween M100 latency and social functioning has yet to be observed in
clinical populations. Relationships of middle latency responses latency
to language functioning are also not clear. M50/M100 response laten-
cies have been observed to predict oral language ability (Oram Cardy
et al., 2008), but such an association was not replicated in later studies
(Roberts et al., 2010). Of note, these later studies suggestedM100delays
are speciﬁc to ASD, as compared to speciﬁc language impairment
(Roberts et al., 2012). It is likely that sample size considerations in the
context of ASD heterogeneity (including variability in language impair-
ment in ASD)may account for study differences. Furthermore, it is pos-
sible that M100 latency delays reﬂect system dysfunction common to
both ASD and language impairment.
In addition to M100 latency, STG auditory post-stimulus gamma-
band activity (typically N30 Hz) has received considerable attention as
a candidate biomarker for ASD. Though not speciﬁc to ASD (Edgar
et al., 2014a; Krishnan et al., 2009; Maharajh et al., 2007), altered post-
stimulus gamma-band activity has been repeatedly demonstrated in dif-
ferent sensory systems with multiple stimulus complexity paradigms in
children and adults with ASD (Gandal et al., 2010; Grice et al., 2001;
Rojas et al., 2008; Sun et al., 2012; Wilson et al., 2007). Within the audi-
tory system, post-stimulus phase-locked gamma-band measures (i.e.
evoked power aswell as inter-trial coherence) have been found to be re-
duced in ASD (Edgar et al., 2015b, 2016; Gandal et al., 2010; Rojas et al.,
2008;Wilson et al., 2007). Auditory gamma-band alterationsmay repre-
sent heritable endophenotypes, as they are observed in ﬁrst-degree rel-
atives of individuals with ASD (McFadden et al., 2012; Rojas et al.,
2008, 2011), with some evidence that gamma-band activity in relatives
is associatedwith social functioning (Rojas et al., 2011). Although the ex-
istence of post-stimulus gamma-band alterations inﬁrst-degree relatives
may call into question the appropriateness of thismeasure as a diagnostic
or response biomarker, a subclinical expression of social impairments is
thought to exist in the relatives of individuals with ASD, often referred
to as the Broader Autism Phenotype (Piven et al., 1997). As such,
gamma-band biomarkers may support a basis for a clinical discrimina-
tion (Port et al., 2015). Along this line, several recent studies have dem-
onstrated the ability of gamma-band metrics to distinguish between
infants at low and high risk for ASD, where risk is typically operational-
ized as the presence of an older sibling with ASD (Elsabbagh et al.,
2009; Tierney et al., 2012). For example, Elsabbagh et al. (2009) recruited
10-months-old infants, who either had no sibling (low-risk) or one older
sibling (high-risk) diagnosed with ASD. The infants' response to face
stimuli with either a direct or adverted gaze was recorded using EEG.
In low-risk infants, gamma-band responses were signiﬁcantly modulat-
ed by whether the gaze was direct or adverted. In contrast, high-risk
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ferences to the two stimuli (Elsabbagh et al., 2009). Similarly, Tierney
and colleagues (2102) found gamma-band activity alterations in infants
at high-risk versus low-risk for autism. Of note, Tierney and colleagues
(2102) included age groups ranging from 6 to 24 months, allowing
them to characterize developmental trajectories. Tierney and colleagues
found that infants at high-risk for ASD exhibited less frontal resting-state
gamma-band activity versus the low-risk infants at all timepoints. More-
over, there was a trend towards different developmental trajectories in
frontal resting-state gamma-band activity between the low- and high-
risk groups (Tierney et al., 2012). Such ﬁndings, however, may not be
speciﬁc to ASD, as other studies have shown that gamma-band activity
relates to current (Benasich et al., 2008) as well as future (Gou et al.,
2011) cognitive and language abilities. Indeed, Benasich et al. (2008)
demonstrated that frontal resting-state gamma-band activity, but not
lower frequency activity, correlated with concurrent cognitive and lan-
guage functioning in infants 24months of age. Using a similar paradigm,
Gou et al. (2011) demonstrated that frontal resting-state gamma-band
activity at multiple timepoints before 3 years of age predicted cognitive
and language abilities at both 4 and 5 years of age.
Gamma-band activity also has a putative biological basis, with
gamma-band activity hypothesized to arise from local circuit interac-
tions between excitatory pyramidal cells and inhibitory interneurons
(for review see Buzsáki and Wang, 2012). A key feature in multiple
models of gamma-band activity generation is the key role of inhibitory
signaling (Whittington et al., 2000), including the time-constant of
gamma-aminobutyric acid (GABA)A receptors (Traub et al., 1996). As
such, alterations to gamma-band activity in ASD suggest alterations in
local circuit function, particularly the balance of local neural circuit exci-
tation and inhibition. The role of excitatory/inhibitory imbalance in ASD
has been hypothesized for over a decade (Rubenstein and Merzenich,
2003), with several lines of evidence supporting this hypothesis: the
high prevalence of co-morbid epilepsy in ASD (Danielsson et al., 2005;
Yasuhara, 2010), alterations to proteins related to neurotransmitter sys-
tems (Fatemi et al., 2002, 2009a, b, 2014;Oblak et al., 2010; Purcell et al.,
2001) as well as cell-type speciﬁc counts detected ex vivo (Lawrence
et al., 2010; Zikopoulos and Barbas, 2013), and in vivo alterations to
neurometabolites related to excitation and inhibition in ASD (for review
see Rojas et al., 2015).
The aforementioned cross-sectional studies ofM100 latency prolon-
gation and post-stimulus gamma-band alterations in ASD, although in-
formative, have limitations. In addition to the limits inherent to cross-
sectional studies, for example arising from inter-subject “biological”
variability, cross-sectional designs do not allow for developmental
changes over time. This is a particular limitation as some children ini-
tially diagnosed with ASD may show improvement over time, with im-
provement even resulting in “optimal outcome” (Granpeesheh et al.,
2009; Helt et al., 2008; Mukaddes et al., 2014; Zappella, 2002). Though
much remains unknown about “optimal outcome”, research suggests a
small cohort of individuals originally diagnosed with ASD no longer
meet diagnostic criteria at follow-up. Indeed, domain-speciﬁc measures
suggest some individuals with SAD may later function well within the
normal range with respect to cognitive and social abilities (Helt et al.,
2008). The role, impact, and speciﬁcity of interventions associated
with “optimal outcome”, however, are currently unknown. Although it
has been suggested that “optimal outcome” individuals demonstrate
better social skills and higher intelligence relative to the general ASD
population, some of these measures (i.e., higher IQ) do not strongly
predict “optimal outcome”. In addition, initial autism severity is not asso-
ciated with “optimal outcome” (Helt et al., 2008). In addition, it is impor-
tant to note that individuals showing “optimal outcome” often show
subtle residual impairments even after “losing” the ASD diagnosis
(Kelley et al., 2006).With regard to the above, an objective prognostic bio-
marker and/or real-timemonitor of intervention efﬁcacywould be of use.
In an attempt to address the aforementioned limitations of cross-
sectional studies, the present study utilized a longitudinal design toexamine auditory M100 latencies, auditory gamma-band responses,
and their maturation in TD children and childrenwith ASD. The present
study tested the hypotheses that childrenwith ASDwould demonstrate
prolonged auditory M100 latencies as well as reduced post stimulus
phase-locked gamma-band metrics. Longitudinal analyses allowed di-
rect assessment of whether M100 latencies in ASD show within-
subject evidence of abnormal maturation. Given that cross-sectional
ﬁndings show similar rates of M100 latency maturation in TD and
ASD, it was hypothesized that the children with ASD would demon-
strate a persistent prolongation inM100 latency delay against the back-
ground of a similar rate of maturation. Thus, it was hypothesized that
M100 latency in older individuals with ASD does not decrease at a
rate fast enough to ‘catch up’ to age-matched TD latencies.
Use of a longitudinal design additionally allowed examination of asso-
ciations betweenMEGmeasures and current as well as future clinical/be-
havioral status. It was hypothesized that M100 latency would be
associatedwith current autism severity based on the aforementionedpre-
clinical observations of correlations between middle latency responses
and sociability (Billingslea et al., 2014; Saunders et al., 2013). Such an as-
sociation has yet to be demonstrated in a clinical population. Moreover,
an association between M100 latency and current language ability was
hypothesized to be absent (Roberts et al., 2010), building upon previous
studies indicating M100 latency is not related to language ability. Finally,
it was hypothesized that gamma-band activity would be associated with
follow-up language functioning (Gou et al., 2011) aswell as autism sever-
ity (Elsabbagh et al., 2009; Tierney et al., 2012).We hypothesized that al-
though the clinical signiﬁcance of perturbed gamma-band activity in ASD
may not be immediately evident at earlier ages, early gamma-band ab-
normalities would have an downstream effect (Cardin et al., 2009;
Sohal et al., 2009).
2. Materials and methods
2.1. Participants
Initial timepoint 1 data were obtained from previous magnetoen-
cephalography (MEG) studies (Edgar et al., 2015b; Roberts et al.,
2010). A subsample of participants (TD = 9, ASD = 27) were re-
recruited two to ﬁve years later (mean age = 12.1 years). The longitu-
dinal cohort was smaller than our previously published studies because
of a restricted intake age-range (to allow for subsequent follow-up dur-
ing the adolescent period) as well as difﬁculties re-contacting and re-
recruiting participants over a long time interval, and additional exclu-
sion criteria that arose across time (e.g., dental work in the intervening
period, or later medication use).
Of note, a subset of the re-recruited children from the ASD cohort
(N = 5) showed considerable improvement at follow-up, and were
sub-threshold for a diagnosis of ASD at this later time. These individuals
are referred to here as “had ASD”. All 36 participants (9 TD [3males], 22
ASD [22 males], 5 “had ASD” [4 males]) had evaluable M100 data.
Table 1 reports diagnostic scores and demographics for these three
groups (TD, ASD, “had ASD”).
The gamma-bandmeasures were more sensitive thanM100 latency
to artifacts (e.g. motion), which arose primarily from the gamma-band
analysis pipeline relying on subject's MRIs. This is in contrast to the
M100 latency measures which can be extracted from raw sensor data,
if needed, negating the issue of movement within the anatomic MRI
scan. As such, eight children (1 TD, 7 ASD) were excluded from
gamma-band activity analyses due to MRI-related artifacts. This left 28
participants (8 TD [3 male], 15 ASD [15 male], 5 “had ASD” [4 male])
for the gamma-band analyses. Table 2 reports population diagnostic
scores and demographics for the three groups (TD, ASD, “had ASD”) in-
cluded in gamma-band analyses. As the “had ASD” group was consid-
ered too small for statistical analyses (parametric or non-parametric),
the “had ASD” individuals were not included in statistical analyses,
with ﬁndings from this group only descriptively reported.
Table 1
Demographics of M100 study population. No signiﬁcant differences in age (4th block from left) or Wechsler Intelligence Scale for Children-IV General Ability Index (WISC-IV GAI) (5th
block from left) were observed between TD (top), and ASD (middle). Children with ASD exhibited signiﬁcantly higher Social Responsiveness Scale (SRS) and Autism Diagnostic Observa-
tion Schedule Calibrated Severity Scores (ADOS CSS) at both initial and follow-up exams (1st and 2nd block from the right). Wechsler Intelligence Scale for Children-IV Verbal Compre-
hension Index (WISC-IV VCI) scores were signiﬁcantly lower in childrenwith ASD (middle right) at initial exam. ASD children also demonstrated signiﬁcantly lower scores on the Clinical
Evaluation of Language Fundamentals—fourth edition (CELF-4 Core Language Index). A subgroup of children who had an initial diagnosis of ASD no longer met diagnosis criteria at the
follow-up exam (“had ASD” (bottom)). These children exhibited SRS and ADOS CSS scores similar to children with ASD at the initial exam, and then intermediate corresponding scores
at follow-up. These children had similar age and GAI to children with ASD, though intermediate WISC-IV VCI scores. Values are counts or mean (standard deviation). Bold indicates sig-
niﬁcant p values and their associated Cohen's d.
Age (yrs) WISC-IV GAI WISC-IV VCI CELF-4 CLI SRS (raw) ADOS CSS
N Male Initial Follow-up Initial Follow-up Initial Follow-up Initial Follow-up Initial Follow-up Initial Follow-up
Control 9 3 8.4
(1.3)
11.9 (1.5) 116.3
(17.3)
113.8
(20.4)
113.2
(19.0)
110.3
(21.5)
108 (14.6) 105.8
(15.5)
46.3 (7.1) 41.3 (4.4) 1.2
(0.4)
1.3 (0.8)
ASD 22 22 8.4
(1.1)
12.1 (1.3) 104.9
(15.5)
102.2
(15.0)
94.0 (15.8) 97.3 (12.9) 85.3
(17.1)
89.5 (18.0) 75.1 (9.4) 70.5
(12.5)
8.3
(1.8)
7.0 (1.6)
“had
ASD”
5 4 8.7
(0.7)
11.8 (0.4) 102.6 (9.0) 105.6
(13.6)
104.2
(10.1)
109.6 (9.7) 90.8
(12.7)
96.4 (9.7) 75.0
(18.7)
54.4
(12.1)
7.8
(2.7)
2.5 (1.0)
p(TD [top] vs. ASD
[middle])
0.99 0.77 0.11 0.18 0.02 0.15 b0.001 0.02 b0.001 b0.001 b0.001 b0.001
Cohen's d 1.1 1.43 0.97 −3.46 −3.12 −5.45 −4.51
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Akin to procedures described in Edgar et al. (2015b), subjects with
ASD were originally recruited from the Regional Autism Center of The
Children's Hospital of Philadelphia (CHOP), the Neuropsychiatry pro-
gram of the Department of Psychiatry of the University of Pennsylvania
School of Medicine, and from local and regional parent support groups
such as ASCEND (Asperger Syndrome Information Alliance for South-
eastern Pennsylvania) and local chapters of Autism Speaks. All children
screened for inclusion in the ASD sample had a prior ASD diagnosis
made by an expert clinician, typically a developmental pediatrician in
the Regional Autism Center at the Children's Hospital of Philadelphia.
The original diagnosis was made after an extensive clinical interview,
documentation of DSM-IV criteria for ASD, and use of various ASD diag-
nostic tools, such as the Childhood Autism Rating Scale and, in many
cases, the ADOS. Subjectswith typical development (TD)were recruited
through local newspaper advertisements and frompediatric practices of
the CHOP primary care network.
Research participants made two visits to CHOP in addition to any
prior clinical visits. During the ﬁrst visit (2–3 weeks prior to the MEG
exam), clinical and diagnostic testing was performed to conﬁrm the re-
ferral ASD diagnosis, to administer neuropsychological tests, and to en-
sure that the TD children met study inclusion/exclusion criteria.
Assessments were performed by licensed child psychologists with ex-
pertise in autism (L.B., E.S.K.). Given the extensive clinical evaluations
uponwhich original ASDdiagnosiswasmade, an abbreviated diagnosticTable 2
Demographics of gamma-band study population. Identical to theM100 study population: no sig
IV General Ability Index (WISC-IV GAI) (5th block from left) were observed between TD (top),
Scale (SRS) and Autism Diagnostic Observation Schedule Calibrated Severity Scores (ADOS CSS
gence Scale for Children-IVVerbal Comprehension Index (WISC-IV VCI) scoreswere signiﬁcantly
signiﬁcantly lower scores on the Clinical Evaluation of Language Fundamentals—fourth edition
no longermet diagnosis criteria at the follow-up exam (“had ASD” (bottom)). These children ex
intermediate corresponding scores at follow-up. These childrenhad similar age andGAI to childr
prehension Index WISC-IV VCI scores. Values are counts or mean (standard deviation). Bold in
Age (yrs) WISC-IV GAI WISC-IV VCI
N Male Initial Follow-up Initial Follow-up Initial Fo
Control 8 2 8.4
(1.4)
12.1 (1.5) 118.3
(17.5)
116.0
(21.0)
114.4
(20.0)
11
(2
ASD 15 15 8.6
(1.1)
12.2 (1.3) 104.9
(13.6)
105.2
(15.0)
95.1 (14.3) 10
(1
“had
ASD”
5 4 8.7
(0.7)
11.8 (0.4) 102.6 (9.0) 105.6
(13.6)
104.2
(10.1)
10
p(TD [top] vs. ASD
[middle])
0.80 0.89 0.09 0.25 0.03 0.2
Cohen's d 1.11battery conﬁrmed the original diagnosis. Speciﬁcally, the ASD diagnosis
was conﬁrmedwith standard diagnostic tools, including direct observa-
tion with the Autism Diagnostic Observation Schedule (ADOS; Lord
et al., 2000)) and parent report on the Social Communication Question-
naire (SCQ; Rutter et al., 2003). Dimensional symptom severity ratings
were also obtained by parent report on the Social Responsiveness
Scale (SRS; Constantino and Gruber, 2012). The Autism Diagnostic
Interview-Revised (ADI-R), a parent interview about current and prior
ASD symptoms, was utilized to resolve diagnostic discordances be-
tween the ADOS and parent rating scales in the rare instances in
which such discordances occurred. At the time of their original study
visit, children were required to exceed established cut-offs on both
the ADOS and SCQ, or, in the event of a discordance between thosemea-
sures, on both the ADOS and ADI-R. Children 1 point below ADOS cut-
offs were included if they also exceeded cut-offs on at least two parent
questionnaires or on the ADI-R. For children for whom original diagno-
sis was not made by an expert clinician according to DSM criteria
(e.g., diagnoses made by a school), more rigorous standards were ap-
plied, and the child was required to exceed cut-offs on both the ADOS
and ADI-R for inclusion in the ASD group. For ﬁnal inclusion in the
ASD group, children had to meet the above criteria at the time of their
original study participation and also had to exceed diagnostic cut-offs
on theADOS at their two to ﬁve -year follow-up (parent rating scale cor-
roboration was not required at follow-up). To rule out global cognitive
delay, all subjects were required to score at or above the 2nd percentile
(SS N 70) on the Perceptual Reasoning Index (PRI) of the Wechslerniﬁcant differences in age (4th block from left) orWechsler Intelligence Scale for Children-
and ASD (middle). Children with ASD exhibited signiﬁcantly higher Social Responsiveness
) at both initial and follow-up exams (1st and 2nd block from the right). Wechsler Intelli-
lower in childrenwith ASD (middle right) at initial exam. ASD children also demonstrated
(CELF-4) Core Language Index. A subgroup of children who had an initial diagnosis of ASD
hibited SRS and ADOS CSS scores similar to childrenwith ASD at the initial exam, and then
enwith ASD, though intermediateWechsler Intelligence Scale for Children-IV Verbal Com-
dicates signiﬁcant p values and their associated Cohen's d.
CELF-4 CLI SRS (raw) ADOS CSS
llow-up Initial Follow-up Initial Follow-up Initial Follow-up
2.3
2.4)
110.3
(13.8)
108.9
(13.3)
46.4 (7.6) 40.1 (3.3) 1.2
(0.4)
1.3 (0.8)
1.0
2.2)
88.9 (12) 93.2 (11.8) 74.6
(10.5)
71.5
(14.5)
8.1
(1.7)
7.4 (1.6)
9.6 (9.7) 90.8 (12.7) 96.4 (9.7) 75.0
(18.7)
54.4
(12.1)
7.8
(2.7)
2.5 (1.0)
5 b0.001 0.01 b0.001 b0.001 b0.001 b0.001
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570 R.G. Port et al. / NeuroImage: Clinical 11 (2016) 566–577Intelligence Scale for Children-IV (WISC-IV;Wechsler, 2003). In all sub-
jects, the WISC-IV Verbal Comprehension Index (VCI) was also
obtained.
Inclusion criteria for the TD children included scoring below the cut-
off for ASD on all domains of the ADOS aswell as parent questionnaires,
and performance above the 16th percentile on the Clinical Evaluation of
Language Fundamentals—4th edition (CELF-4; Semel and Wiig, 2003).
In addition to the above inclusion/exclusion criteria, all subjects and
families were native English speakers and had no known genetic syn-
dromes or neurological (e.g., cerebral palsy, epilepsy), or sensory (hear-
ing, visual) impairments.
TD children were free of medications at both exams, except for one
participantwhowas prescribed Naltrexone at follow-up. In the children
with ASD, 12were prescribedmedications/took dietary supplements at
the ﬁrst scan. At follow-up, 14 tookmedications/supplements. The “had
ASD” cohort did not report taking medications at the initial exam. At
follow-up 3 “had ASD” participants were taking medication. Supple-
mental Table 1 provides medication information.
The studywas approved by the CHOP Institutional ReviewBoard and
all participants' families gave written informed consent. As indicated by
institutional policy, where competent to do so, children over the age of
seven gave verbal assent.
2.3. Electrophysiological data collection
MEG data were obtained using a whole-cortex 275-channel system
(VSM MedTech Inc., Coquitlam, BC) in a magnetically shielded room.
Prior to data acquisition, three head-position indicator coils were at-
tached to the participant's scalp at the nasion and left- and right-
preauricular points. These head coils provided continuous speciﬁcation
of head position and orientation in relation to theMEG sensors. Tomin-
imize fatigue during the task, participants viewed (but did not listen to)
a movie projected onto a screen positioned at a comfortable viewing
distance. Electrodeswere attached to the left and right clavicles for elec-
trocardiogram recordings (ECG) and to the bipolar oblique (upper and
lower left sites) for electro-oculogram recordings (EOG). A band-pass
ﬁlter (0.03–300 Hz) was applied to the EOG, ECG, and MEG signals,
with signals digitized at 1200 Hz, and with third-order gradiometer en-
vironmental noise reduction of the MEG data.
After theMEG session, structuralmagnetic resonance imaging (sMRI)
including T1-weighted, 3DMP-RAGE anatomical images for source local-
ization was acquired on a 3 T Siemens Verio™ scanner (Siemens
Healthcare, Erlangen, Germany) with voxel size 0.8 × 0.8 × 0.9 mm3.
2.4. Stimuli
Stimuli consisted of sinusoidal tones presented using Eprime v1.1.
Tones were presented via a sound pressure transducer and sound con-
duction tubing to the participant's peripheral auditory canal via ear-tip
inserts (ER3A, Etymotic Research, IL). Prior to data acquisition, 1000 Hz
tones (300 ms duration, 10 ms rise time) were presented binaurally
and loudnessmonotonically decreased until reaching auditory threshold
for each ear. Stimulus toneswere then presented at 45 dB sensation level
above threshold. During the task participants passively listened to binau-
rally presented interleaved 200, 300, 500 and 1000 Hz sinusoidal tones
(tones of 300 ms duration; 10 ms ramps) with a 1000 ms (±100)
inter-trial interval. Participants heard a total of 130 tones/frequency.
2.5. Data preprocessing
MEG responses were analyzed using the MatLab (Mathworks, Na-
tick, MA) open-source toolbox, Fieldtrip (Oostenveld et al., 2011).
Using the continuous data and the procedures outlined in Fieldtrip
(FieldtripWiki, 2015a, b), independent component analysis identiﬁed
heartbeat and eye-movement artifacts (blinks and saccades), and then
these artifact components were removed from the stimulus-lockedepoched data (±500 ms around trigger). Trials with jump and muscle
artifact were also rejected (using Fieldtrip's Z-score based artifact rejec-
tion). Lastly, to account for differences in head motion during the MEG
scan, if any ﬁducialmoved N10mm from the average head position dur-
ing a trial, that trial was rejected.
Subject-speciﬁc single-shell head models were created from each
participant's MP-RAGE MRI. To coregister MEG and sMRI data, the
three anatomical landmarks (nasion and right and left preauriculars
points) as well as an additional 200+ points on the scalp and face
were digitized for each participant using the Probe Position Identiﬁca-
tion (PPI) System (Polhemus, Colchester, VT), and a transformationma-
trix that involved rotation/translation between the MEG and sMRI
coordinate systems was obtained via a least-squares match of the PPI
points to the surface of the scalp and face. This head model was then
ﬁtted to the mean head position (in MEG coordinate space) as deter-
mined by the ﬁducials (Fig. 1A). Separately, the participant's MRI was
normalized to an age-matched average brain template (Fonov et al.,
2011) using non-linearwarping. A left and right Heschl's Gyrus location
was identiﬁed and then reverse transformed to subject space. A
linearly-constrainedminimum variance (LCMV) beamformer was com-
puted for each participant's left and right Heschl's Gyrus, discarding the
contralateral hemisphere's sensors to reduce inter-hemispheric signal
cancelation due to correlated activity (Herdman et al., 2003). Heschl's
Gyrus virtual electrodes (VE) were then computed using a dipole orien-
tation optimized for post-stimulus gamma-band activity (i.e. orienta-
tion determined via principal component analysis on the 0–270 ms
post-stimulus window ﬁltered 30–58 Hz).
2.6. M100 data analysis
For each group, over 92% of trials remained after motion and artifact
rejection (TD = 95.3 ± 1.29%, ASD = 92.7 ± 0.82%). A LMM assessed
differences in the number of trials remaining between diagnostic
groups. In this LMM, aswell as all subsequent LMMs, datawere original-
lymodeledwith the relevantﬁxed factors alongwith random intercepts
for Subjects and random slopes for Timepoint. If the random factors
proved redundant, the random slopes of Timepoint were removed and
the model reran. LMM of the trials remaining for M100 latency analysis
utilized random intercepts for Subjects and random slopes of Timepoint.
This analysis showed a trend towards a main effect of Diagnosis
(F(1,29.02) = 3.02, p b 0.10), and a marginally signiﬁcant main effect
of Timepoint (F(1,28.9) = 4.01 initial = 95.3 ± 0.98, follow-up =
92.7 ± 1.00, p= 0.052). The interaction of Diagnosis × Timepoint was
not signiﬁcant, nor was any term involving stimulus frequency. Al-
though a group difference in number of evaluable trials was suggested,
rejection rates across groups were considered low, and given generally
similar mean values between the groups, this difference was deemed
unlikely to affect any group difference M100 latency ﬁnding.
Determination of the latency of M100 sources in the left and right
Heschl's Gyrus was accomplished using the data from the above analy-
ses pipeline. In each participant, a 3–40 Hz band-pass ﬁlter was applied
and then the left- and right-hemisphere M100 peaks identiﬁed as the
largest point in theM100 scoringwindow (90–190ms) using the sensor
butterﬂy plot of the band-passed ipsilateral channel ERFs. To conﬁrm
that the M100 was accurately identiﬁed, magnetic ﬁeld topographic
plots over all ipsilateral sensors at the selected latency were examined
to ensure a topography reﬂecting a M100 dipolar source.
Given a M100 latency dependence on stimulus frequency (Roberts
and Poeppel, 1996), and given that M100 responses are occasionally
missing/unidentiﬁable for individual stimulus tone frequencies, M100
analyses were performed using LMM with both random intercepts for
Subjects and random slopes for Timepoint, with pairwise comparisons
on themarginal means for Diagnosis, Timepoint, Hemisphere, Condition,
as well as the Diagnosis × Hemisphere and Diagnosis × Timepoint,
and Diagnosis × Timepoint × Hemisphere interactions. To investigate
M100 latency maturation, LMMs were used to create a tone-frequency
Fig. 1. Gamma-band activity analyses. (A) Head models were generated from each
subject's structural MRIs and centered at the average head position. Trials where any
ﬁducial moved in any direction N10 mm from this average position were rejected.
(B) After normalizing individual MRIs to an age-matched template, Heschl's Gyrus was
non-linear reverse source interpolated. (C) A LCMV beamformer (with only ipsilateral
sensors included) at subject space Heschl's Gyrus was used to generate virtual electrode
time courses. (D) Left and right STG time courses were used to obtain time frequency
measures (evoked, total power, ITC) using in-house scripts. Arrow points to gamma-
band activity response.
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M100 latencieswere thenused to compute a rate ofmaturation: (follow-
up M100 effective latency− initial M100 effective latency) / change in
years. A LMMwith random intercepts for Subjects investigated statistical
differences in rate of maturation, with pairwise comparison for Diagno-
sis, Hemisphere and Diagnosis × Hemisphere.
2.7. Gamma-band data analysis
For each group, over 93% of trials remained (TD = 95.2 ± 0.83%,
ASD = 93.1 ± 0.61%). A LMM analogous to that used for testing of
group differences in number of artifact-free M100 trials showed amarginally signiﬁcant main effect of Diagnosis (p= 0.052), and a main
effect of Timepoint (F(1,21) = 5.28; initial =95.0 ± 0.62, follow-
up = 93.3 ± 0.64, p b 0.05). The interaction of Diagnosis × Timepoint
was not signiﬁcant, although ASD, but not TD, demonstrated a gain in
the number of trials between initial and follow-up exams. Although a
group difference in the number of evaluable trials was suggested, rejec-
tion rates across groupswere considered low, and given generally similar
mean trial values between the groups, this difference was deemed un-
likely to affect any group difference gamma-band ﬁnding.
Broadband resultant VE timecourses were time-frequency trans-
formed via Hilbert transforms using in-house MatLab scripts. For each
participant, evoked power, total power (evoked and induced power)
and inter-trial coherence (ITC) were calculated. Mean power/coherence
was then derived for the spectrotemporal regions containing a gamma-
band response. To avoid erroneously quantifying gamma-band activity
by either a) not correctly accounting for gamma-band response matura-
tion, or b) including low-level non-stimulus related signal, gamma-band
responses were quantiﬁed based on a time-frequency region capturing
both TD and ASD group-level activity (initial scan — evoked power: 10–
180 ms, 30–100 Hz, ITC: 10–170 ms 30–65 Hz, total power: 20–180 ms,
30–58 Hz; follow-up scan — evoked power: 10–170 ms, 30–100 Hz,
ITC: 10–150 ms, 30–75 Hz, total power: 20–160 ms, 30–57 Hz).
Gamma-band analyseswere performed using LMMs, with pairwise com-
parisons on Diagnosis, Hemisphere, Timepoint, Diagnosis × Hemisphere,
Diagnosis × Timepoint, and Diagnosis × Time-point × Hemisphere. To
test maturation group differences, a gamma-band activity maturation
measure was computed: (follow-up gamma-band activity metric− ini-
tial gamma-band activity metric) / change in years.2.8. Associations with behavior
To test hypotheses regarding the relationship of MEG measures to
clinical measures as well as to examine the speciﬁcity of such associa-
tions, LMMswith random intercepts for Subjects examined associations
between MEG measures and scores on a measure of ASD symptom se-
verity (Social Responsiveness Scale, SRS; Constantino et al., 2003)), a
measure of language functioning (CELF-4 core language index), a mea-
sure of global cognitive function (WISC-IVGAI), and ameasure of verbal
comprehension (WISC-IV VCI). With MEG measures as the dependent
variable, in separate runs, LMMs examined associations with each of
the above behavioral measures, co-varying for Timepoint and Age. As
such, the association between the MEG measure and behavioral metric
were obtained while concurrently removing variance due to Timepoint
and Age.
Hierarchical regressions tested thehypotheses that initialMEGactiv-
ity explained additional variance in the follow-up behavioral metrics
(SRS, CELF-4 CLI, WISC-IV GAI & VCI) beyond the variance accounted
for by initial behavioral measure and age. As such, the Dependent Vari-
able of BehavioralMetric at follow-upwasmodeledwith Age and Initial
BehavioralMetric as Independent Variables entered intomodelﬁrst and
then MEG measure entered second.3. Results
As shown in Table 1, TD versus ASD did not differ on age at initial
exam or at follow-up. As expected, children with ASD had higher SRS
and ADOS Calibrated Severity Scores (CSS) (Gotham et al., 2009; Hus
and Lord, 2014) than TD at both exams. No group differences were ob-
served in global functioning (WISC-IV GAI) at either time point. Group
differences in verbal functioning (WISC-IV VCI) were present at the ini-
tial exam but not at follow-up. Children with ASD scored signiﬁcantly
lower on the CELF-4 Core Language Index than TD at both exams. The
population included in gamma-band activity analyses exhibited a pro-
ﬁle similar to the above.
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A main effect of Condition (stimulus tone), F(3,114.62) = 17.53
p b 0.001, showed the expected earlier M100 latencies to higher versus
lower frequency tones (Roberts and Poeppel, 1996); a main effect of
Hemisphere, F(1,154.53)= 111.76, p b 0.001, showed the expected ear-
lier right than leftM100 latencies (Roberts et al., 2000); and amain effect
of Timepoint, F(1,21.77) = 8.52, p b 0.01, showed the excepted matura-
tional change with earlier latencies at follow-up versus initial exam. The
main effect of Diagnosis (ASD versus TD) was signiﬁcant, F(1,23.27) =
7.43, p b 0.05, conﬁrming the a priori hypothesis of delayedM100 laten-
cies in ASDversus TD (TD=122±6.0ms; ASD=141±4.0ms). Simple
effect analyses of a Diagnosis × Hemisphere × Timepoint interaction,
F(2,152.94) = 3.30, p b 0.05, showed earlier M100 latencies at follow-
up versus the initial exam in both groups and both hemispheres except
for no signiﬁcant right-hemisphere changes in TD. Of note, however,
this interaction is potentially confounded due to inter-subject differences
in duration of the inter-exam interval, which ranged from two to ﬁve
years. As such the three-way interaction cannot be simply conceived as
reﬂecting a simple maturation rate. None of the other interaction terms
involving Diagnosis were signiﬁcant. M100 latency values for all groups
at both exams (marginal means after collapsing across condition) are
shown in Fig. 2.
Analyses also examined group differences in the M100 latencymat-
uration rates (i.e., (follow-up M100 effective latency− initial M100 ef-
fective latency) / change in years). Both TD and ASD demonstrated a
~3–5 ms/year M100 latency maturation, with no signiﬁcant differences
for Diagnosis, Hemisphere or their interaction (p N 0.05). Thus both TD
and ASD showed similar maturational shortening of M100 latency.
3.2. Gamma-band activity
To increase signal-to noise, responses were averaged across condi-
tion (shown effective in (Gandal et al., 2010)). As shown in Fig. 3, at
both exams, gamma-band activity was visible in the grand average
time-frequency response for each group.
An LMM (with Subjects as a random intercept) tested for group dif-
ferences in total power. Gamma-band total power did not differ between
TD and ASD at either exam (p N 0.10; data not shown). For evoked power
(tested via LMMwith random intercept for Subject), a main effect of Di-
agnosis, F(1,41.6) = 8.68, p b 0.01, conﬁrmed the a priori hypotheses of
reduced gamma-band evoked activity in ASD (38.4 ± 4.7% change from
baseline) versus TD (61.5± 6.4% change from baseline; Fig. 4A & B). The
main effect of Timepointwas also signiﬁcant, F(1,43.07)=8.04, p b 0.01,
demonstratingmaturationof evoked responsepowerover time (initial=
41.1±3.1% change frombaseline, follow-up=58.8±6.4% change from
baseline; Fig. 4). Themain effect of Hemisphere andHemisphere interac-
tion termswere not signiﬁcant (F(1,43.1) or F(2,43.1) b 0.50, p N 0.1). AsFig. 2.M100 latencies predict diagnosis. (A) t-Tests showed that childrenwith ASD versus TDha
up exam, children with ASD again showed prolongedM100 latencies. The “had ASD” exhibited
between TD and ASDwere present for maturation rates. Intermediate M100 latencymaturation
yses were conducted for only ASD and TD, mean and SE values are also shown for “the had” Asuch, responses are collapsed across hemispheres for Fig. 4. Additionally
the Diagnosis × Timepoint interaction term was not signiﬁcant
(F(1,43.1)=2.56, pN 0.1). The rate of change in evoked gamma-band ac-
tivity for TD (7.7±3.0% change frombaseline/year)was not signiﬁcantly
different fromASD (2.1±2.2% change frombaseline /year; F(1,38.44)=
2.30, p N 0.1, Fig. 4). Again, themain effect of hemisphere and it's interac-
tion term were not signiﬁcant (F(1,38.44) b 0.98, p N 0.1), and so data
were collapsed across hemisphere in Fig. 4.
For gamma-band ITC (tested via LMM with random intercepts for
Subjects and Timepoint as a random slope), a main effect of Diagnosis,
F(1,22.24) = 6.30, p b 0.05, indicated greater ITC in TD versus ASD
(ASD= 0.040 ± 0.003 ITC, TD= 0.053 ± 0.004 ITC). Both the main ef-
fect of Timepoint and its interactionwith Diagnosis were not signiﬁcant
(F(1,19.9) b 0.55, p N 0.1). Additionally, similar to evoked power, the
main effect of Hemisphere and Hemisphere interaction terms were
not signiﬁcant (F(1,42.02) = 0.41, F(2,42.02) = 0.98, p N 0.1). As such,
responses were again collapsed across hemispheres. As shown in
Fig. 4, analyses examining ITC maturation (LMM with random inter-
cepts for Subjects) showed no signiﬁcant group differences. As with
evoked powermaturation, themain effect of Hemisphere and the inter-
action terms were not signiﬁcant (F(1,21) = 1.3, p N 0.1). As such, data
were collapsed across hemisphere in Fig. 4.
3.3. Correlation of MEG auditory biomarkers and behavioral metrics
Data from all participants (including “had ASD”) were included in
the correlational analyses. To ensure speciﬁcity of any associations and
to provide negative controls, all comparisons between behavioral met-
rics and MEG-derived measures (excluding rates of maturation) were
examined. Of note, the behavioral measures (SRS, CELF-4 CLI, WISC-IV
GAI, WISC-IV VCI) shared considerable variance, especially the CELF-4
CLI, WISC-IV GAI and WISC-IV VCI, with up to 80% variance shared;
see Supplemental Table 2 for bivariate correlations among behavioral
measures. For all subsequent analyses, gamma-band activity, but not
M100 latencies, were averaged across hemisphere due to the lack of sig-
niﬁcant effects of Hemisphere. Examining all participants at both
timepoints, both left- and right-hemisphere M100 latencies were asso-
ciated with SRS after removing variance associated with Age and Time
(LH: SRS F(1,54.30) = 6.48 p b 0.05, estimate = 0.2 ms/SRS point, RH:
SRS F(1,62.38) = 15.20 p b 0.001, estimate = 0.2 ms/SRS point;
Fig. 5). No associations were observed for CELF-4 Core Language Index
or WISC-IV metrics (GAI/VCI) in either hemisphere (p N 0.1), or for
any gamma-band metric.
Although M100 latency did not correlate with current language
scores, right-hemisphere initialM100 latency predicted additional vari-
ance in the follow-up CELF-4 Core Language Index metric (R2 change =
0.03, p b 0.05). In addition, a trend was observed for an association be-
tween initial evoked gamma-band power and follow-up WISC-IV VCId prolonged left and right-hemisphereM100 latencies at the initial exam. (B)At the follow-
non-signiﬁcant intermediate M100 latencies at both timepoints. (C) No group differences
(as compared to TD and ASD) rates are exhibited by the “had ASD” cohort. Although anal-
SD group. #p b 0.10, *p b 0.05.
Fig. 3. Childrenwith ASD exhibit reduced gamma-band evoked power. (A) Group average evoked power plots for TD children (left) at initial exam (upper, A) and follow-up exam (lower,
C) show the auditory gamma-band post-stimulus response. At both time points, children with ASD (right) showed reduced gamma-band responses (initial exam— upper, B; follow-up
exam — lower, D). Dashed box shows gamma-band ROI used.
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dicted additional variance in follow-upWISC-IV VCI after removing the
effect of age and initial WISC-IV VCI score (R2 change = 0.05, p b 0.05).
Thus, theseMEGmeasure may offer a prognostic indication of language
outcome, perhaps signifying “capacity for improvement”.Fig. 4. Children with ASD exhibit reduced gamma-band evoked power and inter-trial coheren
(A) and follow-up exam (B). The “had ASD” group exhibited qualitatively intermediate respon
reduced four-fold in ASD versus TD. ITC (bottom row) demonstrated a similar pattern, though3.4. Qualitative description of “had ASD”
As previouslymentioned, a third group of participants emerged over
the course of the study — the “had ASD” group. Although too small for
statistical assessment, data from these participants are included asce. Evoked power (top row) responses were reduced in children with ASD at both initial
ses at both time-points. Maturation of the evoked gamma-band response (upper C) was
not signiﬁcant at initial exam. #p b 0.10, *p b 0.05.
Fig. 5. M100 latencies and SRS scores. Effective right-hemisphere M100 latencies
(removing effect of condition) were associated with social responsiveness scores across
the study population. ***p b 0.001.
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proﬁle similar to the primary ASD group at the initial exam (Tables 1 &
2, SRS = 75.0, ADOS CSS = 7.8). At follow-up, however, these partici-
pants had intermediate SRS and ADOS scores (Tables 1 & 2, SRS =
54.4 ADOS CSS=2.5). Such “optimal outcomes” have beendemonstrat-
ed before, with such children tending to have initial language/commu-
nication scores that predict outcome (Helt et al., 2008). Consistent
with this, these ﬁve children scored between TD and ASD on the
WISC-IV VCI at both time points (initial = 104.2, follow-up = 109.6).
With regard to M100 latencies, as shown in Fig. 2A, M100 latencies
in the “had ASD” group at the initial exam were either similar to TD
(left hemisphere) or intermediate between TD and ASD (right hemi-
sphere). As shown in 2B and 2C, this proﬁle was also observed at
follow-up as well as for the M100 latency maturation rate measure. In
addition, “had ASD” showed gamma-band evoked power and ITC values
between TD and ASD at the initial and follow-up exams. Follow-up
studies are needed to conﬁrm if this represents an electrophysiological
signature of “capacity for improvement”.
4. Discussion
M100 latencies and phase-locked gamma-band evoked power ma-
tured from initial to follow-up exam. This ﬁnding supports ﬁndings
from cross-sectional studies (Paetau et al., 1995; Rojas et al., 2006). In
addition, similar to previous studies (Edgar et al., 2015a, b, 2016; Gage
et al., 2003b; Roberts et al., 2010, 2013; Wilson et al., 2007), delayed
right-hemisphere M100 latencies and reduced bilateral gamma-band
evoked power and ITC were observed in ASD versus TD. Of note, con-
trary to previous studies, left-hemisphere M100 group differences
were also observed in ASD, with resolution of bilateral M100 latency
ﬁndings in the present study perhaps attributable to greater statistical
power in a longitudinal study. As such, the observation of bilateral
M100 latency delays questions the hemispheric speciﬁcity of prosody
versus phoneme processing in ASD alluded to in the introduction, at
least at ~100 ms. Rather than local processing of speech related sounds,
M100 latency deﬁcits may be driven by hemispherically non-speciﬁc
white-matter microstructural integrity alterations leading to reduced
conduction velocity (Dockstader et al., 2012; Roberts et al., 2009;
Stufﬂebeam et al., 2008). Such a statement is supported by the bilateral
phase-locked gamma-band activity ﬁndings, which did not show any
hemisphere effect, suggesting that local circuitry in both auditory corti-
ces are perturbed in ASD rather than a hemisphere-selective deﬁcit.Interestingly, in the present studyM100 latency delays were greater
than those reported in previous studies (Edgar et al., 2015b; Gage et al.,
2003b; Roberts et al., 2010, 2013), an effect perhaps due to the use of
cross-sectional designs in previous studies. In particular, whereas
cross-sectional studies likely include some children that later exhibit
“optimal outcome”, in the present study, diagnostic change information
was available and the ASD subjects showing signiﬁcant improvement
were excluded from the primary analyses. Indeed, reanalysis of the
data for timepoint 1 including the “had ASD” individuals in the ASD
group (as would have happened in a cross-sectional design) decreased
the effect size by severalmilliseconds (although signiﬁcant groupdiffer-
ences were still exhibited).
Maturation rates for M100 latency as well as the gamma-band met-
rics did not differ between TD and ASD, a ﬁnding that conﬁrms previous
cross-sectional maturation rate estimates (Edgar et al., 2014b; Roberts
et al., 2013) As such, present ﬁndings support ﬁndings from previous
studies suggesting a perturbed developmental trajectory, despite a sim-
ilar maturation rate, that is due to a very early in development latency
offset.
Analyses examined the relationship of the two auditory biomarkers
to current and future behavior. Four separate, though related, behavior-
almetricswere tested in order to examine the speciﬁcity of associations.
Right- and left-hemisphere M100 latencies were associated with great-
er clinical impairment, here quantiﬁed as higher SRS scores. To the au-
thors' knowledge, this is the ﬁrst time such associations have been
demonstrated.
Although analogous relationships were not observed for the gamma-
band metrics, initial gamma-band ITC predicted variance in follow-up
WISC-IV VCI scores. Gamma-band evoked power exhibited a similar,
though non-signiﬁcant, relationship to WISC-IV VCI scores. Somewhat
unexpectedly, right M100 latencies also predicted change in CELF-4
Core Language Index scores. Although in previous studies gamma-band
metrics predicted future cognitive and language abilities (Gou et al.,
2011), such associations have not been previously reported for M100 la-
tencies. Although the ﬁnding of current right-hemisphere M100 associa-
tions with subsequent CELF-4 Core Language Index score may appear
contradictory given the lack of association with contemporaneous be-
havior, a potential explanation may be that language-related issues aris-
ing from M100 latency prolongations are cumulative. As such, the later
language-related measures are taken the greater the observed language
deﬁcit for some subjects. Thus, it is hypothesized that a M100 latency
delay relates to diminished capacity for language improvement and
also that an earlier M100 latency predicts the availability of capacity for
improvement. Given “capacity” for improvement, the degree of improve-
ment will likely depend on interventions in the follow-up interval, and
thus the M100 latency measure is suggested as a prognostic/predictive
biomarker for future intervention studies. Previous cross-sectional stud-
ies examining associations between M100 latency and general language
ability are inconsistent (Oram Cardy et al., 2008; Roberts et al., 2010,
2013), perhaps due to the prevalence, as well as variety, of language im-
pairments in ASD or the fact that the language measure was taken con-
currently with the M100 measurement. Of note, the M100 latency
delay in children appears to be speciﬁc to ASD, at least in comparison
to children with speciﬁc language impairment (SLI) (Roberts et al.,
2012).
A few study limitations are of note. First, a potential confound is the
gender bias (more females in the control group). In a separate analysis,
previously collected and published datasets were investigated for gen-
der effects for M100 latency and gamma-band evoked power and ITC
(Edgar et al., 2015b; Roberts et al., 2010). The main effect of Gender
was not signiﬁcant for any analysis. Gender therefore likely does not
confound present ﬁndings.
A second limitation is that children were only scanned twice with a
two to ﬁve year inter-scan interval. Multiple time points are required to
determine if the ﬁndings observed here extend to other developmental
periods, for example before or after the age range sampled in the
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of statistical tendencies in maturation rates that did not reach signiﬁ-
cance in the present study. Multiple timepoints and an extended
study age-range would also permit the consideration of non-linear de-
pendencies of observed variables on age.
Finally, given the small sample, statistical analyses could not be per-
formed on the “has ASD” cohort. In these children, M100 latency and
gamma-band ﬁndingswere qualitatively observed to be intermediate be-
tween TD and the remaining ASD group, suggesting that these auditory
neural measures may serve as prognostic biomarkers. These ﬁndings are
only suggestive though, and a larger cohort is needed to conﬁrm and es-
tablish the precision/sensitivity of the above observations. As noted in the
Introduction, the endogenous, environmental or therapeutic factors that
contribute to clinical change are currently unknown. The literature on
“optimal outcomes”, however, does indicate that in children who exhibit
“optimal outcome” subtle impairments persist (Orinstein et al., 2015), a
ﬁnding supported in the present study via the observation in “had ASD”
of auditory neural measures at follow-up with values between TD and
ASD. In future studies with larger samples, quantitative assessments of
the intervention/treatments the children with ASD receive are needed
to help identify the basis and/or mechanism for improvement.
To conclude, the present longitudinal study demonstrated altered
auditory M100 and gamma-band neural activity in children with
ASD. These abnormalities were persistent over the maturation peri-
od observed (several years). Electrophysiological measures correlat-
ed with and predicted subsequent change in behavioral measures.
The children with ASD who showed clinical improvement appeared
to have somewhat more intermediate electrophysiological ‘abnor-
malities’ at ﬁrst and follow-up exams. As such, present ﬁndings sug-
gest that the auditory neural measures investigated in this studymay
serve as prognostic biomarkers, with further study needed to vali-
date such ﬁndings.
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